vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT
· Real-Time Price · USD
20.50
-1.91 (-8.52%)
At close: Oct 17, 2025, 3:59 PM
21.13
3.07%
After-hours: Oct 17, 2025, 04:10 PM EDT
vTv Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 1.02M | n/a | 2.02M | 4M |
Cost of Revenue | 89K | 90K | 92K | 89K |
Gross Profit | 928K | -90K | 1.93M | 3.92M |
Operating Income | -24.18M | -25.5M | -22.54M | -21.66M |
Interest Income | 1.56M | 472K | 352K | 1K |
Pretax Income | -22.61M | -25.97M | -24.87M | -17.62M |
Net Income | -18.46M | -20.25M | -19.16M | -12.99M |
Selling & General & Admin | 13.65M | 11.91M | 12.2M | 12.34M |
Research & Development | 11.55M | 13.51M | 12.36M | 13.32M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 25.2M | 25.41M | 24.56M | 25.67M |
Interest Expense | n/a | 13K | 15K | 12K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 25.2M | 25.5M | 24.56M | 25.67M |
Income Tax Expense | 100K | n/a | 200K | 115K |
Shares Outstanding (Basic) | 5.77M | 2.08M | 1.92M | 1.57M |
Shares Outstanding (Diluted) | 5.77M | 2.08M | 1.92M | 1.57M |
EPS (Basic) | -3.2 | -9.71 | -9.98 | -8.29 |
EPS (Diluted) | -3.2 | -9.71 | -9.98 | -8.29 |
EBITDA | -22.52M | -25.86M | -24.77M | -17.52M |
EBIT | -22.61M | -25.95M | -24.86M | -17.6M |
Depreciation & Amortization | 89K | 90K | 92K | 89K |
Source: Financial Modeling Prep. Financial Sources.